We are live on ! Find out more
IMUX icon

Immunic
IMUX

51 hedge funds and large institutions have $51.5M invested in Immunic in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $344K | Put options by funds: $130K

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

5% less capital invested

Capital invested by funds: $54.5M → $51.5M (-$2.98M)

6% less funds holding

Funds holding: 54 → 51 (-3)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
13
Closed
6
Calls
$344K
Puts
$130K
Net Calls
+$214K
Net Calls Change
-$43K

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$14.3M
2
BCM
Bridgeway Capital Management
Texas
+$555K
3
BFA
BlackRock Fund Advisors
California
+$444K
4
SEI Investments
SEI Investments
Pennsylvania
+$323K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$69.1K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.45M
2
CS
Credit Suisse
Switzerland
-$91.3K
3
ARTA
A.R.T. Advisors
New York
-$84K
4
VKH
Virtu KCG Holdings
New York
-$78K
5
SG Americas Securities
SG Americas Securities
New York
-$76K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$94K – – –
RJA
27
Raymond James & Associates
Florida
$90K – – –
NFA
28
Nationwide Fund Advisors
Ohio
$88K – – –
AIG
29
American International Group
New York
$83.5K – – –
CS
30
Credit Suisse
Switzerland
$81K -$91.3K -37 -53%
BA
31
BlackRock Advisors
Delaware
$69K – – –
PPA
32
Parametric Portfolio Associates
Washington
$66K -$12.3K -5 -16%
HighTower Advisors
33
HighTower Advisors
Illinois
$61K – – –
EA
34
Emerald Acquisition
Washington
$55K -$44.4K -18 -45%
Wells Fargo
35
Wells Fargo
California
$49K – – –
Morgan Stanley
36
Morgan Stanley
New York
$39K +$19.7K +8 +100%
Bank of America
37
Bank of America
North Carolina
$25K -$29.6K -12 -55%
Deutsche Bank
38
Deutsche Bank
Germany
$23K -$19.7K -8 -44%
Legal & General Group
39
Legal & General Group
United Kingdom
$23K – – –
Citigroup
40
Citigroup
New York
$21K +$22.2K +9 New
Fifth Third Bancorp
41
Fifth Third Bancorp
Ohio
$18K – – –
ZB
42
Zions Bancorporation
Utah
$15K – – –
CG
43
Cutler Group
California
$13K -$4.93K -2 -25%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$9.8K +$4.93K +2 +100%
BlackRock
45
BlackRock
New York
$9K – – –
Barclays
46
Barclays
United Kingdom
$8K +$4.93K +2 +200%
IF
47
Ironwood Financial
Arizona
$5K – – –
Creative Planning
48
Creative Planning
Kansas
$4K – – –
UBS Group
49
UBS Group
Switzerland
$3K +$2.47K +1 New
TCIM
50
TIAA CREF Investment Management
New York
$497 – – –
1
2
3

IMUX Hedge Fund Activity: Q3 2016 in Review

51 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2016, worth a combined $51.5M — down 5.5% from $54.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMUX and 5 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 12 added.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $14.3M. The largest seller was Fidelity Investments, cutting an estimated $3.45M.

  • 51 institutional investors held Immunic (IMUX) as of Q3 2016, down from 54 in Q2 2016.
  • Funds reported $51.5M of Immunic stock for Q3 2016, down 5.5% quarter-over-quarter.
  • 5 funds opened new Immunic positions in Q3 2016 and 6 closed out, a net change of -1 holder.
  • The largest Immunic buyer in Q3 2016 was Victory Capital Management, an estimated $14.3M added.
  • The largest Immunic seller in Q3 2016 was Fidelity Investments, an estimated $3.45M sold.

Based on aggregated 13F filings for Q3 2016.